Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions. 

 

View bio business grants awarded by year.
image of Ohad Gafni, PhD
Ohad Gafni, PhD
Human hematopoiesis in genetically modified swine
Our goal is to engineer a humanized swine model that carries key human cytokines, this strategy will provide the immunology field a high capacity…
2019-2020
image of Dominique Davidow, PhD
Dominique Davidow, PhD
Automation of cell culture with a Terumo Quantum Cell Expansion System to create recellularized bioengineered whole organs
Perfusion decellularization and recellularization are patented technologies owned by Miromatrix Medical Inc. Upon complete removal of cellular…
2019-2020
image of Frank H. Burton, PhD
Frank H. Burton, PhD
Therapeutic & IP optimization of provisionally-patented anti-inflammatory wound healing-accelerant
This project is performing translational studies on a wound-healing accelerant that has been provisionally patented. Animal studies showed that…
2019-2020
image of Vanesa Alonso-Camino, PhD
Vanesa Alonso-Camino, PhD
Development of technolgy for the large-scale production of a novel dendritic cell vaccine for the treatment of glioblastoma
We plan to isolate and expand glioblastoma (GBM) cells from commercially available fresh tumor tissue. These cells will be used to create tumor…
2019-2020
Timothy D. O'Brien, DVM, PhD
Timothy D. O'Brien, DVM, PhD
Development of a Cellular Therapy for Parkinson's Disease
Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.  In the present proposal we will evaluate critical…
2018-2019
image of Joseph S. Uzarski, PhD
Joseph S. Uzarski, PhD
Development of a Perfusion-Based Testing System to Evaluate Short-Term Function in Bioengineered Kidney Grafts
Miromatrix is working to create a new source of kidney grafts for thousands of patients suffering from kidney failure who are wait-listed for…
2018-2019
image of Zachary Resch, PhD
Zachary Resch, PhD
Increased Application of Novel Regenerative Therapeutics Achieved Through Integrated CGMP Process Development Optimization
The Mayo Clinic CRM Biotrust has the role of escalating promising cellular and acellular biologics from bench to clinical-grade products, through…
2018-2019
image of James R. Dutton, PhD
James R. Dutton, PhD
Building a Stem Cell Innovation and Business Incubator Facility at the UMN Stem Cell Institute
Funding to equip laboratory space at the UMN Stem Cell Institute to provide a shared-space Innovation and Prototype Facility to support start-up…
2018-2019
image of Alicia Wallis, PhD
Alicia Wallis, PhD
Miltenyi CliniMACS Equipment Grant
Equipment for CD34 cell isolation and selection in our planned cGMP operation for regenerative medicine.
2018-2019
image of Satsuki Yamada, MD, PhD
Satsuki Yamada, MD, PhD
Multi-Modal Imaging Platform for Monitoring Regenerative Therapy
This proposal aims to establish the state‐of‐the‐art ultrasound platform armed with photoacoustic technology specialized for regenerative therapies…
2018-2019
image of James R. Thompson, PhD
James R. Thompson, PhD
Molecular Farming of BMPs and Fibronectin
The goal of this project is to prove that commercial production of regenerative proteins can be made consistently and with a significant cost…
2018-2019
James Thompson, PhD
Molecular farming to reduce cost of recombinant proteins important to regenerative medicine
After completing "proof of concept" experiments that produced human proteins in tobacco plants and acquiring a new lab facility, we seek to upscale…
2017-2018